Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julie Ann Mabalot Luk"'
Autor:
Marian Iwamoto, Bo Jin, Larissa Wenning, Robert A. Riesenberg, Julie Ann Mabalot Luk, John A. Wagner, Matt S. Anderson, William D. Hanley, Jeffery A. Chodakewitz
Publikováno v:
The Journal of Clinical Pharmacology. 50:1461-1466
A randomized, placebo-controlled, 2-period crossover study in subjects on methadone maintenance therapy was conducted to assess the effect of the HIV-1 integrase inhibitor, raltegravir, on the pharmacokinetics of methadone. Twelve HIV-negative male a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185c3dd9a79d47df75a33027785761e4
https://doi.org/10.1177/0091270009360981
https://doi.org/10.1177/0091270009360981
Autor:
Ajay Nirula, Kenneth C. Lasseter, Eseng Lai, Ying-Hong Wang, Julie Ann Mabalot Luk, Amy O. Johnson-Levonas, Thomas Marbury, N. Martin Lunde, John A. Wagner, Fang Liu
Publikováno v:
Journal of clinical pharmacology. 51(3)
This open-label study evaluated the influence of hepatic insufficiency on the pharmacokinetics of laropiprant (LRPT), a prostaglandin D 2 receptor-1 antagonist, to guide clinicians in the event of inadvertent dosing in patients with hepatic insuffici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45aad90887da53a468580dd71fed0c6
https://pubmed.ncbi.nlm.nih.gov/20484612
https://pubmed.ncbi.nlm.nih.gov/20484612